This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board to review September 2026 quarterly and half-year results
TIRUMALCHM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 3.0 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
No financial results were provided. The board will meet on 5 November 2026 to review and approve the company’s unaudited financial results for the quarter and half-year ended 30 September 2026.
This is only a meeting notice. Share price impact cannot be assessed until the actual results are published.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹596.5 Cr | ₹445.4 Cr | +33.9% |
| Operating profit | −₹39.88 Cr | −₹52.16 Cr | loss narrowed |
| Profit after tax | −₹34.31 Cr | −₹33.38 Cr | loss widened |
| EBITDA margin | 6.5% | -0.8% | +7.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.